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The study of murine systemic lupus erythematosus (SLE) 1 has revealed that several 
abnormalities controlled by multiple genes play a role in this autoimmune disease (1- 
4). Both B and T  cell abnormalities have been reported, and the relative importance 
of a  given defect varies from strain  to strain  (1,  2, 5, 6).  For example,  T  helper cell 
hyperfunction plays a  dominant  role in the disease of MRL/1 mice (6-10), whereas 
primary  B  cell  abnormalities  have  been  identified  in  BXSB,  NZB,  and  (NZB  × 
NZW)F1  (NZB/W)  mice  (1,  2,  6,  11-14).  In fact,  these  latter  mice,  unlike  MRL/1 
mice  (7,  9),  develop  SLE  despite  neonatal  thymectomy  (1,  2,  7,  15).  Additionally, 
male BXSB early-life SLE can be transferred  with  anti-Thy-l.2  +  complement  (C) 
treated  male bone marrow cells  given  to thymectomized, lethally  irradiated  female 
BXSB recipients. 2 
It is now clear that  normal  B  cells require several signals to become activated,  to 
proliferate,  and  to undergo  differentiation  to  antibody-producing ceils  (16,  21).  In 
this study we have used in vitro assays for which two or more identifiable signals are 
necessary to obtain B cell responses and compared lupus mice versus normal control 
mice in regard to: (a) the number of signals required for activation and differentiation 
and  (b)  the  magnitude  of responsiveness  to  these  signals.  Our hypothesis  was  that 
hyperactive B  cells  from SLE mice might  bypass certain  of the signals required  by 
normal  B  cells,  i.e.,  they  might  need  fewer  stimuli  to  differentiate  or  they  might 
respond abnormally to the stimuli. 
We have found that B cells from young BXSB and NZB/W  mice give heightened 
responses to almost all stimuli tested. In particular, defects were noted in the regulation 
of IgM to IgG switching.  Nevertheless, we found no evidence that the B cells of SLE 
mice could proliferate or secrete antibody in the absence of appropriate T  cell- and/ 
or macrophage-derived  signals.  These  findings  indicate  that  primary  B  cell  defects 
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found  in  some,  but  not  all,  SLE  strains  of mice  depend  on  accessory cell-derived 
signals for expression. 
Materials  and  Methods 
Mice.  C57BL/6  (H-2b), "BALB/c  (H-2d),  C3H/St  (H-2K),  DBA/2  (H-2d),  and 
NZB/W (H-2 d/~) mice are bred and maintained in the Scripps Clinic animal colony. BXSB 
(H-2 b) and MRL/Mp-lpr/lpr  (MRL/1, H-2 k)  mice, which were developed by Murphy and 
Roths (3) and originally obtained from The Jackson Laboratory, Bar Harbor, Maine, are bred 
and maintained in the Scripps Clinic animal colony. All mice used in this study were 20-25-d 
old females, except the BXSB strain from which early SLE developing male mice of the same 
age were used. The mortality rates, serologic, histologic, and cellular characteristics of the SLE 
strains have been reviewed elsewhere (1). 
Preparation of T  Cell-depleted Populations and Culture Conditions. To deplete T  cells, spleen cell 
suspensions  were  treated  with  monoclonal  anti-Thy-l.2  (NEI-001,  New  England  Nuclear, 
Boston, MA) and guinea pig C. This treatment completely abrogated the response to concan- 
avalin  A  (Con  A).  In  some  experiments  spleen  cells were  treated  with  a  combination  of 
monoclonal  anti-Thy-l.2, anti-Lyt-1, and anti-Lyt-2 (all from  New  England  Nuclear)  and 
guinea pig C. For assaying responses to various stimuli, B  cells (104 to 5  ×  105 cells/250 gl 
medium)  were  incubated  in  96  well, flat-bottomed microtiter plates  (Falcon 3072,  Beeton 
Dickinson, Oxnard, CA). Medium consisted of RPMI  1640 supplemented with 25 mM Hepes 
(M.  A. Bioproduets, Walkersville, MD)  50 gM 2-mercaptoethanol, penicillin (50  units/ml)- 
streptomycin (50 gg/ml) mixture (M. A. Bioproducts, Walkersville, MD), and  10% fetal calf 
serum (FCS) (lot 29101276, Flow Laboratories). Cells were cultured in the presence of 7% CO2 
at 37°C. 
In some experiments B cells were activated with bacterial lipopolysaccharide (LPS) or with 
Sepharose-bound  anti-g.  LPS  R595  derived  from  Salmonella minnesota (Calbiochem-Behring 
Corp., La Jolla, CA) was used at a concentration of 2.5 gg/ml. The preparation of Sepharose- 
bound  affinity purified anti-g has  been  described (10).  Anti-g was  added to  cultures  at  a 
concentration of 2.5 gg per well. 
Proliferative responses to LPS or anti-g were assayed on  day  3 of culture, after an  18-h 
incubation with 1 gCi [aH]thymidine per well. 
Plaque-forming Cell Assay. Ig secreting cells (IgSC) were quantitated with a reverse hemolytic 
plaque assay as previously described (6). IgSC were counted after 4 d of culture. 
Production of Supernatants. Con A supernatant (CAS) and a B cell differentiation factor secreted 
spontaneously by cultured lymph node T  cells of older MRL/1 mice (L-BCDF) were produced 
as previously described (10).  Briefly, CAS was derived from C57BL/6  (B6) spleen cells (6-10- 
wk old mice)  incubated for 2  h  with 4 gg/ml of Con  A  (Miles Laboratories, Elkhart, IN), 
washed, and re-cultured for 24 h in the absence of Con A. L-BCDF was produced by incubating 
MRL/1 lymph node cells from 4-mo old mice for 24 h in medium without mitogens. CAS and 
L-BCDF were added at a  concentration of 40%  vol/vol to cultures, since previous titration 
studies  (10)  have shown  at  this concentration optimum  responses of activated B  cells from 
several normal and autoimmune strains. 
Radioimmunoassays. The radioimmunoassays used to measure IgM, IgG1, IgG2a, IgG2b, and 
IgG3 in culture supernatants have been described (10, 22). Briefly, for the IgM assay polystyrene 
plates were coated with goat anti-mouse g-chain specific antibody, after which various dilutions 
of each sample were added to the wells. Bound lgM was detected with 125I-goat anti-mouse/z 
antibody. 
The IgG isotype-specific radioimmunoassays were direct binding assays. Plates were incu- 
bated with 100% supernatant, followed by addition of one of the following rabbit anti-mouse 
antibodies: Anti-IgG1, anti-IgG2a, anti-IgG2b, or anti-IgG3, all purchased from Litton Bio- 
netics  (Kensington,  MD).  The  assay was  developed with  12SI-labeled  goat  anti-rabbit IgG, 
Specific absorptions  were  performed  to  reduce  the  cross-reactivity of the  antibodies,  and 
standard curves were established for each assay by coating the plates with graded amounts of 
mouse myeloma proteins of each isotype and subclass, also purchased from Litton Bionetics. 
In Vitro Responses to Sheep Erythrocytes (SRBC). This assay was performed at a B cell density of 
2 ×  105 cells/ml as described by Zubler and Glasebrook (21). Cells were cultured in medium as PRUD'HOMME  ET AL.  1817 
mentioned above (10% FCS)  in 24 well, 3524 Costar plates (Costar, Cambridge, MA) in the 
presence or absence of SRBC, LPS, CAS, or L-BCDF. SRBC were added at a concentration of 
2 ×  106/ml; LPS was added at a concentration of 2.5 #g/ml; CAS and L-BCDF were added at 
40% vol/vol. After 5 d of culture at 37°C with 7% (]02, without rocking, indirect anti-SRBC 
plaque were assayed. 
Results 
LPS- and Anti-#-mediated  Proliferation in Low and Medium Density Cultures. In a previous 
study, we reported on the proliferative responses of splenocytes from various murine 
strains to LPS and anti-# in high cell density cultures  (5 ×  105/250 #1)  (12).  At that 
density there was no consistent difference in proliferative responses of young autoim- 
mune and young normal mice. At the high cell density, cellular confluence or rapid 
exhaustion  of the  media may have prevented a  maximal proliferative response.  In 
contrast, splenocytes of 1-mo old NZB and NZB/W mice cultured at a  medium cell 
density (105 cells/250 #1) in the presence of LPS had 5- to  10-fold higher frequencies 
of IgSC than spleen cells from the other autoimmune strains or several normal strains 
(6).  In the present study, at medium (105 cells/250 #1)  and low cell density (5  ×  104 
cells/250 #1), both BXSB and NZB/W anti-Thy-l.2 +  C  treated spleen cells showed 
considerably higher responses to LPS than MRL/1 ceils or cells from immunologically 
normal strains (Fig.  1). Nevertheless, at 104 cells/250 #1 proliferation was undetectable 
or slightly lower than  that  of control cells cultured  in  medium alone in  all strains 
tested, unless CAS was added (Table I). BXSB and NZB/W were more responsive to 
CAS  than  other  strains  under  these  conditions.  The  MRL/1  Thy-l.2 +,  Lyt-l.2* 
proliferating cell product L-BCDF had no effect in this assay. 
The  proliferative  response  to  anti-#  was  even  more sensitive  to  changes  in  cell 
density than with LPS. As reported by others (19), we found that normal B cells in 
low density cultures no longer proliferated in response to anti-# (Fig. 2). In fact, at 5 
X  104 cells/well anti-# had a  slight suppressive effect, giving counts lower than cells 
in medium alone. B  cells of BXSB and NZB/W, but not MRL/I, mice gave higher 
responses  than  those  of the  other  strains  tested  and  were  the  only ones  to show  a 
positive response at  a  density  of 5  ×  104  cells/well.  However, at  104  cells/well  no 
proliferation could be detected in any strain tested. This response was not restored by 
CAS or L-BCDF  (data not shown).  Proliferation in response to anti-# is thought  to 
depend on the presence of B cell growth factor (BCGF) (19), presumably produced by 
residual T  cells in high density cultures. BXSB and NZB/W B cells may thus be more 
sensitive to low levels of BCGF than B cells of other strains. 
Effect of CAS and L-BCDF on LPS-induced IgM Secretion in Low Density Cultures. At cell 
densities as low as 5 ×  104 cells/250 #1, in the presence of LPS BXSB and NZB/W B 
cells produced considerably more IgM than MRL/1, BALB/c, and B6-derived B cells 
(Table II). This response was enhanced by the addition of either CAS or L-BCDF. At 
a cell density of 104 cells/250 #1 there was an abrupt decline in production of IgM in 
all strains, disproportionately to the decrease in cell numbers. However, even at this 
low density, IgM production could be enhanced by CAS or L-BCDF, and both BXSB 
and NZB/W were more responsive to these stimuli than the other strains. 
Effect  of L-BCDF and CAS on Anti-#-treated  B  Cells. Anti-#  alone  induced  little  Ig 
secretion in any strain tested, regardless of cell density (Fig. 3 A). When L-BCDF was 
added, a  marked increase in the number of IgSC was noted.  BXSB and NZB/W B 
cells did not differ from normal strains in their requirement for L-BCDF in this assay, 1818  ACCESSORY  SIGNALS IN MURINE  LUPUS 
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but gave higher responses than other strains. This finding held for concentrations of 
L-BCDF ranging from  20  to 80%  vol/vol (data not shown).  The results with anti-/z 
plus CAS differed in that this response was dependent on cell density (Fig. 3 B). Thus, 
at  a  cell  density of 5  ×  104  cells/250 /~1, none  of the  strains  responded,  including 
BXSB  and  NZB/W.  We  have  described  this  cell  density  effect  before  (10)  and 
attribute it to a  need for residual interleukin-2 dependent T  cells in this assay. Thus, 
at  a  low  cell  density,  too  few  residual  T  cells  (and  ?  macrophages)  seemed  to  be 
present for a  detectable CAS-mediated response. Yet  at higher cell densities (1-5  × 
105 cells/250 ~1), activated B cells of BXSB and NZB/W  mice showed higher responses 
to CAS than MRL/1 or normal mice. 
CAS and L-BCDF Induced Ig Secretion in Nonmitogen-Treated B Cells. In this assay both 
CAS and L-BCDF increased the number of IgSC. The responses of B cells from BXSB 
and NZB/W  mice were several-fold higher than those of control mice (Table III). It PRUD'HOMME ET  AL. 
TABLE  I 
LPS-lnduced Proliferation in Low Density Cultures 
1819 
[SH]Thymidine  uptake (A cpm)* 
B cell origin 
10  4 cells/well  5 X t0  4 cells/well 
LPS*  LPS +  LPS +  LPS  LPS +  CAS  LPS + 
CAS  L-BCDF  L-BCDF 
BALB/c  -  176  926  -283  2,387  5,254  2,108 
B6  -665  647  -701  5,391  10,782  4,900 
BXSB  8  3,072  -55  32,877  48,021  33,720 
NZB/W  -42  1,845  83  10,410  26,042  11,215 
MRL/1  41  983  -  19  3,690  10,490  2, 711 
* Assayed at day 3 of culture. 
* LPS was added at a concentration of 2.5 #g/ml. CAS or L-BCDF was added at a concentration of 40% 
vol/vol. Varying the concentration of L-BCDF from 10 to 80% vol/vol did not significantly alter the 
results.  Values listed represent the mean of three experiments and  were derived by substraction of 
proliferative responses in cultures of cells with medium alone.  Negative values indicate lower responses 
than those obtained with cells in medium alone. 
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FIG.  2.  Anti-/t induced proliferation in low to medium cell density cultures.  See the legend to Fig. 
1 for experimental conditions. A cpm ±  1 SD =  [aH]thymidine uptake with Sepharose-bound anti- 
/~ (2.5 #g anti-~/well) -  [aH]thymidine uptake with medium. The response of other normal strains 
tested not depicted (C3H/St, DBA/2) were similar to the response of BALB/c, B6, and MRL/I 
mice. 
has been suggested that only activated B  cells respond to antigen nonspecific helper 
factors (21).  If this is the case, then BXSB and NZB/W  mice may have an increased 
number  of spontaneously activated B  cells as others have indicated (13). On the other 1820  ACCESSORY  SIGNALS  IN MURINE  LUPUS 
TABLE II 
LPS-Induced IgM Secretion in Low Density Culture 
IgM (ng/ml)* 
Strain of origin  10  4 cells/well  5 ×  10  4 cells/well 
of B cells 
LPS +  LPS +  Me-  LPS +  LPS + L-  Medium  LPS  LPS  CAS  L-BCDF  dium  CAS  BCDF 
BALB/c  < 10  12  50  52  51  230  1,023  603 
B6  < 10  19  86  61  50  674  1,648  1,362 
BXSB  < 10  28  192  171  45  1,368  2,044  1,860 
NZB/W  <10  30  180  153  66  1,056  2,072  1,632 
MRL/1  < 10  18  82  67  47  613  1,432  1,211 
* IgM was measured by radioimmunoassay  after 6 d of culture.  See Table I for culture conditions. The 
results represent the mean of three experiments. One SD did not exceed 12% of the mean  for values 
above  10 ng/ml. BXSB and NZB/W gave higher responses than other strains at all concentrations  of 
CAS and L-BCDF tested (10-80%). 
hand,  activation  may  occur  in  vitro  in  this  assay due  to  the  possible presence  of 
mitogens, or antigens (e.g., FCS) in the culture medium. 
Response to SRBC in Low Density Cultures. Zubler and Glasebrook (21)  have demon- 
strated  that  in  low cell density cultures  (2  ×  105  B  cells/ml)  the addition of CAS, 
mixed lymphocyte culture supernatant  (MLC-SN), or the products of cloned T  cell 
lines was insufficient to reconstitute the primary in vitro response to SRBC.  Even in 
the presence of both LPS and SRBC, no response was observed. However, with three 
signals  present,  i.e.,  antigen  (SRBC),  LPS,  and  CAS  or  MLC-SN,  a  response  was 
elicited. We have  obtained similar results using B  cells from  several strains and  we 
believe that,  in  this  assay,  LPS  replaces a  signal  normally mediated  by T  cells or 
macrophages but absent from CAS. 
As can be seen from Table IV, all strains tested required the three signals (SRBC, 
CAS, and LPS) to give a  high response. However, BXSB and NZB/W  B cells differed 
from  those of the other  mice by  generating responses  of disproportionately greater 
magnitude. This finding is consistent with the higher sensitivity of the latter B cells to 
both LPS and CAS. However, we cannot exclude that other genetically determined 
factors may contribute to this hyperresponsiveness. Interestingly, L-BCDF could not 
replace CAS in this assay. 
IgG Isotypes Produced Following  LPS Stimulation.  We  previously reported  that  LPS- 
activated  B  cells produce  increased  amounts  of IgG1,  IgG2a,  and  IgG2b  when  L- 
BCDF  is  added  to  the  cultures  (10).  We  also  reported  and  confirm  in  the  present 
study (Table V) that MRL/1 B cells produced increased amounts of IgG2a in response 
to LPS, possibly due to their in vivo exposure to L-BCDF. BXSB and NZB/W  B cells 
produced much  more IgG than normal strains or MRL/1  B  cells in response to LPS 
(Table  V).  This  result  paralleled  their  high  proliferative response  and  high  IgM 
production  stimulated  by  LPS.  In  addition,  LPS  activated  BXSB  and  NZB/W  B 
cells produced higher percentages of IgG2a and IgG2b, but less IgG3, than control B 
cells. 
These results resemble those we obtained following in vivo thymus independent-1 
(TI-1)  antigen  injections  (23).  This  high  level of IgG2  production  could  reflect  an 
increased rate of switching secondary to the magnified proliferative response to LPS PRUD'HOMME ET  AL.  1821 
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FIC.  3.  Anti-la induced differentiation. (A) Splenic B cells from various  strains were cultured for 
4 d in the presence of Sepharose-bound anti-/~ (2.5/tg/well) at cell densities ranging from 5 ×  104 
cells/250 #l to 5 X 105 cells/250 p.l, in the absence or presence of 40% vol/vol L-BCDF.  Stimulation 
index ±  1 SD =  Experimental/medium control, as assessed by number of IgSC per well. With anti- 
tt alone, the response of all strains was low and closely similar.  (B) Response at various cell densities 
to anti-/t +  40% vol/vol CAS. Other normal strains tested (B6, C3H/St) did not differ significantly 
from BALB/c and MRL/1. 
TABLE  III 
CAS and L-BCDF-Induced Ig Secretion in Nonmitogen-treated  B Cells 
IgSCper culture* 
Treatment  C3H/St  B6  BALB/c  MRL/I  BXSB  NZB/W 
Medium  1:1:2  8:t:2  6:t:3  9:t:3  6+3  6+3 
CAS  14 2:4  19 ±  5  15 2:3  18 2:4  195 +  9  89 +  8 
L-BCDF  71+11  92±12  652:7  87±10  348±21  306±8 
* 105 B cells per well were cultured for 4 d after which IgSC were counted using a reverse hemolytic plaque 
assay. Results represent the mean ±  1 SD of three experiments. 
in these mice. Nevertheless, when L-BCDF  was added, B  cells of BXSB and NZB/W 
mice considerably increased their production  of total  IgG as  did B  cells of MRL/I 
and of normal mice. Addition of L-BCDF  to normal B  cells resulted in a  proportional 1822  ACCESSORY  SIGNALS  IN  MURINE  LUPUS 
TABLE  IV 
Response to SRBC in Low Density Cultures 
Treatment* 
Indirect anti-SRBC PFC/culture* 
B6  BALB/c  MRL/1  NZB/W  BXSB 
Medium  14 ±  13  10 ±  2  12 ±  2  12 ±  2  13 ±  2 
SRBC +  CAS  80 ±  7  72 ±  5  75 ±  5  82 ±6  84 ±  8 
SRBC+LPS  75±5  68±6  62+5  81  ±5  94±7 
CAS +  LPS  95±8  80±5  82±6  114+6  118±7 
SRBC +  CAS +  LPS  830 ±  60  792 ±  72  802 ±  58  1,784 ±  80  1,860 ± 60 
SRBC +  L-BCDF +  LPS  62 ±  6  54 ¢  4  44 ±  5  77 ±  4  79 ±  6 
* 2  ×  105  B  cells/ml  from each  of the  listed  strains  were cultured  for  5  d.  SRBC  were  added  at  a 
concentration of 2 ×  106/ml.  LPS was added at a concentration of 2.5 #g/ml, and CAS or L-BCDF were 
added at a concentration of 40% vol/vol. Varying the concentration of L-BCDF from 10 to 80% had no 
additional effect. 
* Less than 50 plaque-forming cells  (PFC) per culture were generated when only one of SRBC, CAS, LPS, 
or L-BCDF was added.  Results represent the mean ±  I SD of three experiments. 
TABLE  V 
IgG Subclasses Produced Following LPS Stimulation with or without L-BCDF 
Strain of origin of  Total IgG  §  Subclasses secreted (percentage of total IgG) 
B cells cultured  Supernatant  ~: 
with LPS*  (ng/ml)  IgG3  IgG1  IgG2b  IgG2a 
BALB/c  u  --  33  50.1  6.1  25.0  18.8 
L-BCDF  227  6.6  18.5  49.3  25.6 
BXSB  --  797  4.2  10.5  61.7  23.6 
L-BCDF  t ,000  3.0  26.7  46.9  23.4 
NZB/W  --  341  8.2  13.8  46.3  31.7 
L-BCDF  723  6.4  29.0  41.5  23.1 
MRL/1  --  55  16.4  7.3  30.9  45.4 
L-BCDF  560  2.8  16.1  27.5  53.6 
* Splenic B cells were cultured at a density of 5 x  10* cells/well for 6 d in the presence of 2.5 #g/ml of LPS. 
* L-BCDF was added at a concentration of 40% vol/vol. 
§ Total IgG is the sum of the values obtained for the 4 IgG subclasses. IgG subclasses were determined by 
radioimmunoassay. The results represent the mean of three experiments. 
I The response of B6, C3H/St, and DBA/2 B cells not depicted were similar to that by BALB/c cells. 
decrease of IgG3 and increased IgG1, IgG2b, and IgG2a. In SLE mice a proportional 
increase in IgG 1 was most apparent. This demonstrates that Ig switching mechanisms 
in autoimmune mice can still respond to T  cell-derived signals. 
Discussion 
B cell hyperactivity is a feature common to all murine SLE strains. In this study we 
compared  the  responses  of B  cells  from MRL/1,  NZB/W,  and  BXSB  autoimmune 
mice in a number of in vitro assays. We chose assays in which two or more identifiable 
stimuli or signals were necessary to obtain a  response. Our basic hypothesis was that 
hyperreaetive  B ceils might be capable of responding in the absence of one or more 
signals that are normally required  for activation, proliferation, or differentiation  of B 
cells.  We made use of the fact that in very low density cultures  (104 B  cells/250 #1), 
normal  B  cells  virtually  do not  proliferate  or secrete  Ig after  LPS stimulation  (24), 
unless accessory signals found in CAS are added.  Similarly, B cells do not proliferate PRUD'HOMME ET AL.  1823 
in response to anti-p in low cell density cultures, and  do not secrete Ig at any cell 
density, unless T cell-derived factors are provided (19, 25). Presumably, LPS and anti- 
/z prime the  B  cells by inducing them  to express receptors for antigen  nonspecific 
factors that mediate proliferation (e.g., BCGF) or differentiation (e.g., T cell replacing 
factor [TRF], BCDFs)  (18,  19, 21, 25-27). CAS is known to contain several lympho- 
kines, which include interleukins (IL-1, IL-2), BCGF, and conventional TRF. Because 
of this complexity in several assays, we have also tested the response to L-BCDF, a 
factor we recently identified (10). This factor is produced by the proliferating T  cells 
of autoimmune MRL/I mice and induces differentiation of anti-/z- or LPS-activated 
B cells, in the apparent absence of macrophages or T  cells, while having little or no 
effect on B cell proliferation. This L-BCDF lacks IL-2, BCGF, or conventional TRF 
activity (10)  as well as  macrophage-activating factor, interferon, IL-1, and  macro- 
phage Ia recruiting factor (unpublished  results).  Some authors have described pro- 
duction of BCGF (19), BCDFs (26), or TRF (28) by cloned T cell lines. Unfortunately, 
such T  cell lines may produce several factors (19, 29, 30), and purified products are 
not yet available for study. For this reason, we have not at the present extended our 
study to analyze lymphokines derived from T  cell lines. 
We have also  looked at  the in  vitro anti-SRBC  response of autoimmune strains 
since B cells are known to require several signals to respond to this antigen. In fact, it 
has been shown that in low density cultures, even in the presence of LPS, three signals 
are required to induce an anti-SRBC PFC response (21). 
The mice used to study B cell function in this study were all 20-25-d old. This age 
range was chosen because none of the strains tested express significant disease at this 
early age. Thus, B cell abnormalities found at this age are unlikely to be secondary to 
the presence of circulating immune complexes, to the presence of antilymphocytic 
antibodies, or to other factors associated with autoimmunity. 
We found that BXSB and NZB/W, but not MRL/1, B cells have higher proliferative 
responses to anti-/z or LPS than normal mice. However, at a cell density of 104 cells/ 
250/zl proliferation was undetectable in any of the strains tested. Nevertheless, even 
at this low cell density, CAS induced a small degree of proliferation in LPS-activated 
B  cells. Thus, such  proliferation in BXSB and  NZB/W mice, although apparently 
abnormally regulated, is not independent of accessory signals found in CAS. 
The same situation holds for Ig secretion. BXSB and NZB/W secreted abnormally 
large amounts of IgM and IgG in response to LPS. However, at  104 cells/250/zl Ig 
secretion decreased sharply, disproportionately to the decreases in cell numbers, unless 
CAS  or  the  T  cell-derived  factor  L-BCDF  was  added.  The  results  were  similar 
following incubation with anti-/z. Here the situation was more clear-cut since anti-/z 
induced little Ig secretion in any strain tested, regardless of cell density, unless CAS 
or L-BCDF was added. These results suggest that the B cells of NZB/W and BXSB 
mice cannot bypass differentiation signals, presumably of T  cell origin in this case. 
Nonmitogen-stimulated B cells of BXSB and NZB/W mice also responded much 
better in terms of IgSC, to CAS and L-BCDF stimulation than MRL/1 and normal 
mice. This may reflect a higher percentage of spontaneously activated in vivo B cells 
in NZB/W and BXSB as others have proposed (13).  On the other hand, this result 
may indicate that antigens (e.g.,  FCS) and possible mitogens (e.g., 2-ME) present in 
the culture medium have a limited ability to activate B cells. 
The pattern of IgG subclass expression in response to LPS was clearly abnormal in 1824  ACCESSORY SIGNALS IN MURINE LUPUS 
both BXSB and NZB/W mice. Thus, both strains produced higher levels of IgG2a 
and IgG2b, but lower levels of IgG3, than normal mice. As we previously reported 
(10), MRL/I mice also secreted an unusually large amount of IgG2a in this assay. 
The reason for these abnormal responses in autoimmune mice is not clear but does 
not  necessarily represent  a  primary  defect  in  switching  mechanisms  as  such.  For 
example, in vivo exposure to soluble mediators could influence in vitro responses of B 
cells. On the other hand, the high rate of proliferation by BXSB and NZB/W B cells 
in the presence of LPS may give rise to a higher number of switching events resulting 
in more IgG2 secretion. In any case, the addition of L-BCDF increased IgG1 secretion 
considerably in all strains tested. Thus, switching from IgM to IgG1 synthesis appears 
to  remain  T  dependent  in  autoimmune  mice,  as  in  normal  mice  (31,  32).  IgG2 
production  paralleled  the  degree  of proliferation,  but  IgG1  production  did  not, 
suggesting that the signals required for IgM ~  IgG2a, 2b switching are different than 
those required for IgM ---> IgG1  switching. The results we have obtained after LPS 
stimulation in vitro closely simulate the in vivo response to TI-1 antigens, which we 
previously reported  (23).  The  large  content  of IgG  subclasses  2a  and  2b  may be 
explained partially by the high rate of cell division in those mice following an LPS- 
like stimulus. Nevertheless, IgG1 synthesis remains highly T  dependent. 
In the LPS-SRBC assay, in accordance with the studies of Zubler and Glasebrook 
(21), we found that  all strains tested, including autoimmune strains, required LPS, 
SRBC, and CAS to respond. It is noteworthy that, unlike standard TRF assays, this 
assay was  performed at  low cell density  (2  ×  105 cells/ml).  Interestingly, L-BCDF 
could  not  replace CAS  in  this  assay.  This  shows  that  an  additional  signal(s)  not 
present in L-BCDF, either of T  cell or macrophage origin, is necessary to induce a 
response  in  this  assay.  Candidates  as  the  source of this  signal  include  IL-1,  IL-2, 
BCGF,  or  the  recently  described  IL-X  (20).  In  any  ease,  BXSB,  NZB/W  and 
MRL/1  B  cells apparently required the same signals  as normal  B  cells in order to 
respond. 
The findings described above lead to a number of conclusions:  (a) B cell prolifer- 
ation  and  differentiation in  lupus  mice  remain  dependent  on  accessory signals  of 
either macrophage or T  cell origin. (b) BXSB, NZB/W, and MRL/I B cells appear 
to require the same number of signals  as normal  B  cells to undergo polyclonal or 
antigen-directed responses. BXSB and NZB/W, but not MRL/I, B cells differ from 
normal B cells only by the higher sensitivity (or degree of response) to the signals they 
receive. (c)  The regulation of IgM  to IgG switching in response to LPS in vitro is 
disordered  in  NZB/W  and  BXSB  mice,  but  IgG1  production  remains  largely T 
dependent in all SLE strains as in normal mice. 
The  reason  for  this  higher  sensitivity  of  BXSB  and  NZB/W  B  cells  to  the 
immunogenic signals they receive have not been established in the present study. It 
could be caused by better activation by the mitogens or a better response to T  cell- 
derived factors. The first possibility is less likely since our studies  (12)  and those of 
Raveche et al. (13) indicate that B cells of 1-mo-old BXSB and NZB/W mice do not 
show different patterns of LPS- or anti-#-induced activation, i.e., cells in the S+G2+M 
phase of the cell cycle, than normal B cells.  Furthermore, Lyb-5  + B cells, which are 
thought to respond to anti-/~  are present in normal or near normal numbers in SLE 
mice (12). Thus, it appears that the increased response of BXSB and NZB/W B cells 
is not due to recruitment of more B cells by mitogens, but rather to a  true hyperre- PRUD'HOMME  ET  AL.  1825 
sponse of their activated B cells to accessory T  cell-derived signals. We are presently 
investigating the attractive possibility that  these B  cells may express an unusually 
high  number  of membrane  receptors, or have receptors with a  higher affinity for 
antigen nonspecific factors than normal B cells. However, the abnormality may also 
reside at the level of regulatory genes that control cell responsiveness after receipt of 
a signal. Another unanswered question is the role ofT and other accessory cell defects 
in this genetic disease of BXSB and NZB/W mice. One could speculate that  these 
animals'  abnormal  B  cells  are  hyperresponding to  normal  levels of accessory cell 
signals, but overproduction of accessory signals may also occur that could play a role 
in magnifying Ig secretion and inducing IgM to IgG switching. 
To summarize, it appears that B cell hyperactivity in murine strains with SLE-like 
disease  is  not  caused  by  bypassing  certain  accessory signals  necessary  for  B  cell 
proliferation and differentiation. Our present and published studies suggest that  in 
BXSB and New Zealand strains of SLE mice there is an inherent hyperresponsiveness 
of B  cells  to  external  stimuli.  In  contrast,  in  MRL/I  mice  the  B  cells  do  not 
hyperrespond to accessory signals but their proliferating Thy-l.2  +, Lyt-1  +, -2- cells 
hyperproduce B  cell differentiation factors.  Such  abnormal  responses to  accessory 
signals or overproduction of the signals ultimately lead to polyclonal and autoantigen 
specific B cell expansion and Ig gene rearrangement that result in the production of 
pathogenic IgG type autoantibodies and disease. 
Summary 
B cell hyperactivity, a  feature common to all lupus-prone routine strains, may be 
caused by hyperresponsiveness to, overproduction of, or bypassing of certain signals 
required for B cell activation, proliferation, and differentiation. In this study, we have 
compared  the  responses of B  cells  from  three  lupus-prone  strains  of mice  (BXSB 
males,  MRL  and  NZB/W  females)  and  normal  strains  in  a  number of assays  for 
which two or more signals are required to obtain a response. In medium to low density 
cultures of B  cells from BXSB and  NZB/W but not  MRL/1  lupus mice, the cells' 
proliferation induced by bacterial lipopolysaccharide (LPS) or anti-/1 antibody was 
much  higher  than  that  of B  cells  from  normal  controls.  At  low  B  cell  density, 
polyclonal activation by these substances and subsequent Ig secretion were dependent 
on accessory signals present in supernatants of concanavalin A-treated normal lym- 
phocytes (CAS)  or on the MRL/1 proliferating T  cell-derived B cell differentiation 
factor (L-BCDF)  in both lupus-prone and immunologically normal mice. However, 
the  responses of B  cells  from BXSB  and  NZB/W,  but  not  MRL/I,  mice to these 
accessory signals were higher than those of normal mice. Ig synthesis by fresh B cells 
of BXSB and NZB/W mice cultured in the absence of mitogens but in the presence 
of CAS or L-BCDF was higher than by similar cells from other strains, suggesting an 
increased frequency of B cells activated in vivo in these two autoimmune strains of 
mice. The patterns of IgG subclass secretion in response to LPS (without added CAS 
or L-BCDF) were abnormal in all lupus strains, with a predominance of IgG2b and/ 
or IgG2a and low levels of IgG3, contrary to normal B cells for which IgG3 synthesis 
predominated. However, IgG 1 synthesis in vitro by autoimmune and normal B cells 
alike  was  highly  dependent  on  T  cell-derived soluble  mediators.  Antigen-specific 
responses to SRBC in vitro of B cells from all lupus strains, like those of B cells from 
normal  strains,  required a  minimum  of three signals  (antigen,  LPS, T  cell-derived 1826  ACCESSORY SIGNALS IN MURINE LUPUS 
antigen nonspeeific helper factors). Yet, once triggered, B cells of BXSB and NZB/W 
mice gave higher responses than those of the other strains. 
We conclude that B cells of lupus mice have signal requirements similar to those of 
normal  mice.  Nevertheless,  B  cells  of BXSB  and  NZB/W,  but  not  MRL/1,  lupus 
mice hyperrespond or process some accessory signals abnormally. 
Received  for publication 2 December 1982 and in revised  form 14 February 1983. 
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